Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Morena SallabandaM I García-BerrocalJ RomeroV García-JaraboM J ExpósitoD F RincónI ZapataM R MagallónPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
SRS and HSFRT are equally effective and safe for the treatment of BM, with no exceptions among different primary tumors. Disease control, surgery, age, and prognostic scales correlated with OS. However, the lack of survival benefit regarding WBRT might become logical evidence for its omission in a subset of patients.
Keyphrases
- brain metastases
- small cell lung cancer
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- early stage
- minimally invasive
- radiation therapy
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- type diabetes
- squamous cell carcinoma
- patient reported outcomes
- radiation induced
- coronary artery disease
- adipose tissue
- smoking cessation
- insulin resistance
- surgical site infection